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The antidiuretic hormone arginine vasopressin (AVP) regulates water homeostasis, blood pressure and 
a range of stress responses. It is synthesized in the hypothalamus and released from the posterior 
pituitary into the general circulation upon a range of stimuli. While the mechanisms leading to AVP 
secretion have been widely investigated, the molecular mechanisms regulating AVP gene expression 
are mostly unclear. Here we investigated the neurotransmitters and signal transduction pathways that 
activate AVP gene expression in the rat PVN using acute brain slices and quantitative real-time PCR. 
We show that stimulation with L-glutamate robustly induced AVP gene expression in acute 
hypothalamic brain slices containing the PVN. More specifically, we show that AVP transcription was 
stimulated by NMDA. Using pharmacological treatments, our data further reveal that the activation of 
ERK1/2 (PD184352), CaMKII (KN-62) and PI3K (LY294002; 740 Y-P) is involved in the NMDA-
induced AVP gene expression in the PVN. Together, this study identifies NMDA-mediated cell 









Arginine vasopressin (AVP) is a neurohypophysial hormone that plays a central role in the 
homeostatic control of osmotic balance through regulating water reabsorption by the kidneys. 
Dysregulation of this system leads to severe imbalances in body water. For example, in diabetes 
insipidus, failure to synthesise and secrete AVP into the bloodstream (central D. insipidus) or to mount 
an adequate response to AVP in the kidneys (nephrogenic D. insipidus) results in excessive water loss 
with potentially severe consequences (Robertson, 2016). 
AVP is mainly synthesised in magnocellular neurons of the supraoptic and paraventricular nuclei 
(SON and PVN, respectively) of the hypothalamus, whose axons extend into the posterior pituitary. 
AVP is stored in dense-core vesicles in the axon terminals of the magnocellular neurons until released 
into the general circulation in response to hyperosmotic stress such as dehydration or systemic salt 
loading, haemorrhage, or changes in blood pressure mediated by angiotensin II (Bankir et al., 2017). 
AVP is also synthesized in parvocellular sections of the PVN and SON (Ueta et al., 2011). While 
normally inactive, AVP expression in these cells is induced by stress, which is detected through 
afferent inputs from different areas of the brain, including the brain stem. In contrast to magnocellular 
neurons, axons of parvocellular neurons project to other parts of the brain, especially the external layer 
of the median eminence (Papadimitriou and Priftis, 2009). AVP released from these cells activates the 
hypothalamic-pituitary-adrenal (HPA) axis through regulation of the hormones ACTH and CRH and 
regulates stress responses and social behaviour (Aguilera et al., 2008). 
AVP release has been shown to be mediated by a range of stimuli, including hyperosmolality, 
angiotensin II, hemorrhage and other stress stimuli. For example, hyperosmolality causes activation of 
the osmoreceptors projecting to the SON and PVN, leading to depolarisation and phasic activity in the 
vasopressinergic neurons (Israel et al., 2010; Richard and Bourque, 1995). AVP release is also 
stimulated by angiotensin II (Glass et al., 2015) in response to low blood pressure as well as 
haemorrhage (Busnardo et al., 2016), which contributes to preserving the function of the 
cardiovascular system during this life-threatening condition. It has been shown that stimulation of 
AVP release in response to diverse stimuli mainly involves glutamatergic inputs (Bourque and 
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Richard, 2001; Busnardo et al., 2012; Israel et al., 2010; Richard and Bourque, 1995). Magnocellular 
neurons of the SON and PVN express both NMDA and AMPA receptors (Herman et al., 2000; Pak 
and Currás-Collazo, 2002). However, several studies report inconsistent roles regarding their specific 
contribution to inducing AVP secretion and indicate possible functional differences between the SON 
and PVN (Busnardo et al., 2012; Costa et al., 1992; Meeker et al., 1999).  
Under conditions of increased AVP secretion, the AVP stores need to be replenished through AVP 
expression. However, in contrast to the mechanisms mediating AVP release, only a few studies have 
attempted to characterise the molecular mechanisms that regulate AVP transcription in various 
hypothalamic nuclei. For example, it has been shown that circadian AVP transcription in the rat 
suprachiasmatic nucleus (SCN) can be induced by an NMDA-mediated intracellular Ca2+/calmodulin-
dependent kinase IV (CaMKIV) pathway, as well as a separate vasoactive intestinal peptide (VIP) 
receptor subtype 2 (VPAC2)/cAMP/MAPK pathway (Rusnak et al., 2007). However, another study 
failed to demonstrate an increase in AVP transcription in response to treatment with glutamatergic 
agents in the SON in vivo, although the immediate early gene c-fos was induced under the same 
conditions (Kawasaki et al., 2009). There is thus a clear requirement to characterise the receptors and 
signalling pathways that mediate the induction of AVP gene expression in specific hypothalamic 
nuclei. 
Here we investigated the neurotransmitters and signalling pathways that mediate activity-dependent 
AVP gene transcription specifically in the PVN using acute brain slices from the rat PVN. We 
stimulated acute rat PVN slices with glutamatergic agonists and measured the expression of AVP 
using qRT-PCR. We demonstrate that AVP transcription can be induced by direct glutamatergic 
activation of NMDA receptors (NMDARs) in the PVN. Furthermore, using pharmacological 
interventions, we show that the NMDAR-mediated induction of AVP transcription involves CaMKII, 
phosphatidylinositol-3-kinase (PI3K) and extracellular-regulated kinase 1/2 (ERK1/2). Together our 
results give novel insight into the molecular mechanisms that regulate AVP gene expression in the 
PVN of the hypothalamus, a specialised brain structure that is essential for the precise regulation of 




2.1 Analysis of AVP gene expression in the rat PVN using acute brain slices 
To analyse AVP gene expression in the PVN, we employed an experimental paradigm using acute 
coronal slices from rat brain. Each slice was prepared such that it contained the PVN region of the 
hypothalamus (Fig 1A/B). Staining of the slices with a specific AVP antibody confirmed that the 
isolated region contained the PVN, including the vasopressinergic neurons (Fig 1B). In order to obtain 
paired samples for our analyses, the slices were divided into hemispheres and all experiments were 
performed using the paired 2 hemispheres from the same animal. To demonstrate that equal amounts 
of vasopressinergic neurons were present in each hemisphere of a given slice and that no differential 
gene activation took place during the preparation and culture of the slices, we measured AVP 
heteronuclear RNA (hnRNA) and c-fos mRNA levels in the untreated hemispheres using qRT-PCR. 
Importantly, AVP hnRNA was consistently detected in each hemisphere and there was no significant 
difference between AVP hnRNA ΔCt values for paired hemispheres of the same slice (Fig 1C/E). In 
addition, the immediate early gene, c-fos, was used as a marker for general neuronal activation 
(Kovacs, 2008; Miyata et al., 1994). Expression of c-fos mRNA was also detected consistently, and no 
significant difference was measured between c-fos mRNA ΔCt values for each hemisphere of a single 
slice (Fig 1D/E). These data demonstrate that paired PVN slices obtained from the same animal 
contain equal amounts of AVP hnRNA and c-fos mRNA in each hemisphere, thus confirming that 
both hemispheres contain similar numbers of vasopressinergic magnocellular neurons and that the 
neurons from both hemispheres are at a similar level of activity under basal conditions. These slices 
therefore represent an excellent system for the analysis of AVP gene expression in response to 
activation of vasopressinergic neurons of the PVN. 
 
2.2 AVP hnRNA expression is induced by glutamatergic stimulation of the 
PVN 
As AVP secretion is mediated by glutamatergic input into the SON and PVN (Bourque and Richard, 
2001; Busnardo et al., 2012; Israel et al., 2010; Leng et al., 2001; Nissen and Renaud, 1994; Richard 
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and Bourque, 1995) we set out to determine whether glutamine also induces AVP gene expression. To 
ensure that any responses were due to the direct action of the neurotransmitters and other reagents on 
the vasopressinergic neurons of the VPN, the voltage-dependent Na+ channel blocker tetrodotoxin 
(TTX) was used to inhibit afferent input into the neurons of the PVN. TTX application alone did not 
significantly affect the expression of AVP hnRNA (Fig 2A). However, we found that depolarisation of 
the neurons within the PVN by incubation with KCl (50 mM, 2 hours) promoted a significant increase 
in AVP hnRNA (Fig 2B). Importantly, direct stimulation with the neurotransmitter L-glutamate (1 
mM, 2 hours) also promoted a substantial increase in AVP gene expression (Fig 2C). These data 
demonstrate that stimulation of AVP gene expression in the PVN is mediated by glutamatergic 
agonists, thus linking AVP secretion and gene expression to the same neurotransmitter. 
 
2.3 NMDA receptors mediate the glutamatergic stimulation of AVP gene 
expression 
Glutamate can activate a number of different receptors, including NMDA, AMPA and kainate 
receptors. We therefore tested the ability of the specific ionotropic glutamate receptor agonists, 
NMDA, AMPA and kainate (all 50 µM, 2 hours) to induce AVP hnRNA expression in hypothalamic 
slices containing the PVN. As above, all experiments were performed in the presence of TTX to 
isolate the vasopressinergic neurons from inputs that may otherwise originate from various subtypes of 
neurons projecting to the PVN. Importantly, only NMDA promoted a measurable increase in AVP 
hnRNA expression over the control samples (Fig 3A). No significant difference was seen between 
control and AMPA- or kainate-treated samples (Fig 3B,C). To further confirm that NMDARs are 
involved in the stimulation of AVP expression by glutamate, we stimulated paired slices with 
glutamate and pre-incubated 1 hemisphere with the specific NMDA inhibitor D-AP5 (Fig 3D). The 
data show a clear reduction of AVP gene expression in the presence of D-AP5, further confirmation 
that NMDARs mediate (at least in part) the effect of glutamate on AVP transcription. Together, these 
data show that AVP gene expression in the PVN is directly activated by glutamatergic stimulation of 
vasopressinergic neurons and that this activation is mainly mediated by NMDA receptors. 
7 
 
2.4 NMDA-dependent induction of AVP gene transcription in the PVN is 
mediated by signalling pathways encompassing CaMKII, PI3K and 
ERK1/2 
It has been shown that activation of NMDARs results in Ca2+ influx, leading to activation of various 
Ca2+-dependent protein kinases, including Ca2+/calmodulin-dependent protein kinase II (CaMKII), 
which associates with NMDARs in postsynaptic densities (Appleby et al., 2011; Strack and Colbran, 
1998). We therefore pre-incubated hypothalamic slices containing the PVN with the selective CaMKII 
inhibitor KN-62 (10 µM) for 1 hour, followed by stimulation of the slices with NMDA (50 µM, 2 
hours) in the presence of the inhibitor. Incubation with the CaMKII inhibitor significantly abrogated 
the NMDA-induced increase in AVP hnRNA expression, compared to the control hemispheres 
without the inhibitor (Fig 4A). These data demonstrate that CaMKII is required for the transduction of 
the signal emanating from the NMDAR to induce AVP gene expression.  
 
NMDA-induced CaMKII activity has been shown to activate phosphatidylinositol-3-kinase 
(PI3K) in the brain (Appleby et al., 2011; Wang et al., 2007). We therefore tested whether PI3K was 
also required for the NMDAR-mediated increase in AVP gene transcription in the hypothalamus by 
pre-incubating the slices with the selective PI3K inhibitor, LY294002 (10 µM), for 1 hour prior to 
stimulation with NMDA. LY294002 treatment significantly abrogated the NMDA-induced increase in 
AVP hnRNA expression in the PVN compared to the control hemisphere receiving only NMDA and 
no inhibitor (Fig 4B). To confirm this result, we incubated hypothalamic slices with the cell-permeable 
phosphopeptide activator of PI3K, 740 Y-P (Derossi et al., 1998; Williams and Doherty, 1999) (10 
µg/ml, 2 hours), in the absence of NMDA. Activation of PI3K by this approach clearly promoted an 
increase in AVP hnRNA expression (Fig 4C), further demonstrating that PI3K is part of the signalling 
pathway(s) activating AVP gene expression in the PVN. 
The ERK1/2 mitogen-activated protein kinase (MAPK) pathway has been shown to be 
activated in response to NMDAR stimulation in various brain regions (Wang et al., 2007). We 
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therefore incubated hypothalamic slices containing the PVN with or without the selective MEK1/2 
inhibitor, PD184352 (2 µM, 1 hour) and treated both hemispheres with NMDA. Treatment with the 
MEK1/2 inhibitor significantly abrogated the NMDA-induced increase in AVP hnRNA expression 
(Fig 4D), demonstrating that the ERK1/2 MAPK pathway is involved in the induction of AVP gene 
expression in the PVN. Together, our data demonstrate that the NMDAR-mediated increase in AVP 
expression in the PVN is modified by CaMKII, PI3K and the ERK1/2 signalling pathway. 
 
2.5 The PI3K and ERK1/2 MAPK signalling pathways contribute 
independently to hypothalamic AVP gene expression 
Our data demonstrate that the CaMKII, PI3K and ERK1/2 MAPK signalling pathways all contribute 
to the activation of AVP gene expression. A link has previously been observed between the PI3K and 
the ERK1/2 pathways, whereby the PI3K effector Akt activates Ras (Wang et al., 2007), placing PI3K 
upstream of the ERK1/2 signalling module. However, it is also possible that both pathways act in 
parallel (Lake et al., 2016). Therefore, we investigated whether NMDAR-mediated AVP gene 
expression in the PVN was dependent upon the activation of the ERK1/2 pathway by upstream PI3K-
mediated signalling. To do this, we activated AVP hnRNA expression using the PI3K activator, 740 
Y-P and tested the ability of MEK1/2 inhibition to abrogate the stimulatory effect of 740 Y-P. 
However, PD184352 failed to affect AVP hnRNA expression induced by 740 Y-P (Fig 5A), 
suggesting that NMDAR-mediated AVP gene expression in the PVN may indeed involve separate 
pathways dependent on PI3K and ERK1/2, respectively. In this case, it would be expected that 
blocking both pathways would have a greater inhibitory effect on AVP gene expression induced by 
NMDA than blocking only one pathway. We tested this hypothesis by using paired hypothalamic PVN 
slices (hemispheres) treated with NMDA plus the PI3K inhibitor LY294002 that were further treated 
with or without the MEK1/2 inhibitor PD184352. Interestingly, in NMDA-stimulated slices treated 
with both LY294002 and PD184352, the amount of AVP hnRNA expressed in response to NMDA 
stimulation was significantly lower than in slices treated with LY294002 alone (Fig 5B), 
demonstrating that the ERK1/2 MAPK pathway contributes to AVP gene expression independently of 
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PI3K/AKT activation. This result confirmed that the NMDAR-mediated induction of AVP gene 
expression involves separate PI3K- and ERK1/2-dependent components that both contribute to the full 
AVP transcriptional response.  
 
3. Discussion 
In this study we have used acute rat brain slices to investigate the neurotransmitters and cellular 
signalling pathways that regulate AVP transcription in the PVN of the hypothalamus. This 
experimental system allowed us to directly stimulate the AVP-expressing neurons with 
neurotransmitters and specific inhibitors or activators and measure the resulting changes in AVP gene 
expression by quantitative RT-PCR. Using acute slices also enabled us to block the afferent inputs 
from a range of other neurons with TTX to ensure that the changes observed in our experiments are 
due to the direct effect of the added reagents on the PVN. Using this experimental paradigm, we 
demonstrated that direct glutamatergic stimulation of vasopressinergic neurons results in increased 
AVP transcription in acute rat PVN slices. Furthermore, we show that AVP transcription in the PVN is 
induced by activation of NMDARs and that this response is mediated by CaMKII, PI3K and the 
ERK1/2 MAPK pathway. 
 
3.1 AVP gene expression in the PVN is driven by NMDAR-mediated 
signalling pathways 
Our data show that AVP gene expression in the PVN is induced by glutamatergic input. In particular, 
we demonstrate that this is mediated by the activation of NMDA receptors. This observation is in line 
with reports showing that magnocellular neurons in the PVN preferentially express NMDARs 
(Herman et al., 2000) and that stimulation of rat hypothalamic explants with NMDA significantly 
stimulates AVP release (Costa et al., 1992). In addition, it has been reported that NMDA efficiently 
promotes AVP release in “punch” cultures from the rat SON containing mainly magnocellular neurons 
(Meeker et al., 1999), with AMPA and kainite having a significant, but smaller effect. This 
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observation is mirrored by our finding that NMDA initiates a significant increase in AVP gene 
transcription, whereas AMPA and kainite produced only a small, statistically not significant, increase. 
One of the principal characteristics of NMDARs is that their activation and deactivation kinetics are 
much slower than those of the other ionotropic glutamate receptors (Dingledine et al., 1999). The 
vasopressinergic neurons would therefore require a more sustained afferent input to activate AVP gene 
expression. As magnocellular neurons usually store relatively large quantities of AVP in their distant 
processes (in the pituitary), they will only be depleted after extended periods of secretion. The 
potential dependence of AVP transcription on prolonged stimulation would therefore be ideal to 
mediate the replenishment of AVP stores in response to sustained changes in osmolality. In addition, 
the slow deactivation kinetics of NMDARs will allow the magnocellular neurons to fully replenish the 
stores before the pathway is inactivated. 
 
Another important feature of NMDA receptors is that they are permeable for the influx of Ca2+. 
Intracellular Ca2+ can activate various Ca2+-dependent molecules to initiate signalling pathways 
leading to changes in gene expression (Rao and Finkbeiner, 2007). CaM kinases are known to 
associate with NMDARs in postsynaptic densities in a manner dependent on NMDAR-mediated Ca2+ 
influx (Strack and Colbran, 1998).  In addition, NMDAR-dependent Ca2+ influx has been shown to 
couple to CaMKII activation in various brain tissues (Appleby et al., 2011; El Gaamouch et al., 2012; 
Sanhueza et al., 2011; Wang et al., 2004). Here we show that NMDAR-mediated AVP gene 
expression in the rat PVN is dependent on CaMKII, further implicating the NMDAR/Ca2+/CaMKII 
signalling pathway in AVP transcription. NMDARs have also been reported to activate PI3K and thus 
AKT, both through Ca2+ influx and the activation of CaMKII (Wang et al., 2007). Importantly, we 
show in this study that NMDAR-mediated AVP gene expression in the rat PVN is also stimulated by 
PI3K. 
Our data further demonstrate that the ERK1/2 MAPK pathway contributes to the induction of AVP 
transcription in the PVN. Using specific inhibitors in acute rat slice cultures of the PVN, we 
demonstrate that NMDAR-mediated AVP gene expression is directly dependent on ERK1/2 activation 
11 
 
in the rat PVN. This is the first direct demonstration of the requirement for ERK1/2 in mediating AVP 
gene expression in magnocellular neurons of hypothalamic nuclei using acute rat PVN slices.  
Interestingly, the ERK1/2 MAPK pathway has been previously linked to the regulation of AVP 
transcription in other hypothalamic nuclei (Nikitina et al., 2014; Rusnak et al., 2007) and MAPKs 
regulate many important aspects of brain function, including learning and memory (Canal et al., 2011; 
Wang and Peng, 2016). The ERK1/2 pathway can activate various transcription factors that engage the 
AVP gene promoter (Greenwood et al., 2014; Iwasaki et al., 1997; Luckman et al., 1996; Yoshida et 
al., 2006). For example, ERK1/2 may induce the expression of c-fos, which can then bind to activator 
protein 1 (AP1) sites in the AVP promoter to stimulate transcription (Luckman et al., 1996; Yoshida et 
al., 2006). ERK1/2 may also phosphorylate the cyclic AMP response element-binding protein 
(CREB), which can bind to the AVP promoter at cyclic AMP response element (CRE) sites (Iwasaki 
et al., 1997). Indeed, the activation of ERK1/2, as well as the transcription factors CREB and Elk1, 
was observed in the SON of dehydrated rats (Nikitina et al., 2014). This suggested that ERK1/2-
mediated CREB/Elk1 activation may be involved in the induction of AVP transcription. Finally, 
ERK1/2 activation may induce expression and/or activity of CREB3-like protein 1 (CREB3L1), which 
can bind to the AVP promoter G-box and CRE2 sequences (Greenwood et al., 2014). The relative 
contribution of these and other possible transcriptional regulators to AVP gene induction needs to be 
further investigated and may depend on the duration of the hyperosmotic stimulus (Greenwood et al., 
2014).  
It has been reported that PI3K can contribute to NMDAR-mediated activation of the ERK1/2 pathway, 
although the mechanism for this is unknown (Wang et al., 2007). This raises the possibility that PI3K 
activation may also lead to ERK1/2 activation and thus AVP gene expression in the PVN. However, 
we found that the AVP transcriptional response induced by direct activation of PI3K (using a 
phosphopeptide activator) was insensitive to inhibition of MEK1/2. Moreover, we show that co-
inhibition of both PI3K and MEK1/2 resulted in a greater reduction in AVP expression in response to 
NMDA stimulation than inhibition of PI3K alone. Together, these experiments demonstrate that 
induction of AVP transcription by PI3K and ERK1/2 is independent of each other in the rat PVN. 
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Nevertheless, the mechanisms by which NMDAR stimulation mediates the activation of the ERK1/2 
MAPK pathway have not been fully elucidated. However, previous reports suggested that this may 
involve the direct binding of NMDAR subunits to Ras guanine nucleotide releasing factors 
(RasGRFs), leading to activation of Ras and initiation of the Raf/MEK/ERK cascade (Wang et al., 
2007). Thus, activation of NMDARs on magnocellular neurons in the PVN initiates several call 
signalling pathways that contribute to the induction of AVP gene expression. 
In addition to the PVN, other nuclei such as the SON and SCN also produce AVP. It would be 
interesting to investigate whether the mechanisms regulation AVP gene expression are similar or 
distinct in these hypothalamic nuclei. There are very few studies that directly compare gene expression 
in these different nuclei. For example, one study (Ueta et al., 2011) using eGFP-expressing transgenic 
animals has shown that the AVP gene is induced by osmotic challenges in the PVN and SON, but not 
the SCN. This is in line with the function of the SCN to regulate AVP secretion diurnally. Other 
studies investigating the secretion of AVP have also tried to shed some light on this question, although 
sometimes with conflicting results. For example, previous reports used acute hypothalamic explants 
comprising magnocellular neurons of the SON with their axonal projections through the median 
eminence terminating in the neural lobe, which also included the relevant CVOs (Morsette et al., 2001; 
Swenson et al., 1998). These studies suggested that AVP release in the SON can be induced by 
activation of either NMDARs or other glutamatergic receptors (Morsette et al., 2001; Swenson et al., 
1998). However, since the explants used in these studies included the CVOs, co-activation of these 
organs by bath application of excitatory glutamate receptor agonists may have affected the response of 
magnocellular AVP neurons. For this reason, we have included TTX in all experiments to block input 
from any other neurons into the PVN. In addition, the regulation of AVP gene expression is likely (at 
least partly) distinct from its secretion, as described above. It would be interesting to perform more 
detailed comparative studies directly comparing AVP expression in the SON and PVN under 
conditions that block the input form afferent neurons (e.g. by using TTX). In addition, the acute PVN 
slices that we established contain both magno- and parvocellular neurons, both of which can 
synthesize AVP. The stimuli we used (glutamate and NMDA) are likely to activate both types of 
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neurons. In future studies, it would be interesting to differentiate between these cell types to dissect 
any potential differences in the regulation of gene expression. 
 
3.3 Conclusions 
Collectively, our results reveal a novel signalling pathway regulating the activity-dependent induction 
of AVP gene expression in the rat PVN. Our data demonstrate that glutamate binding to NMDARs on 
AVP neurons initiates CaMKII, PI3K- and ERK1/2-dependent signalling pathways that lead to the 
induction of AVP gene expression. Subsequent investigations are necessary to clarify the coupling of 
NMDARs to the Raf/MEK/ERK pathway, and to determine which components act downstream of 
PI3K in inducing AVP transcription. 
 
4. Experimental Procedures 
4.1 Reagent preparation 
L-glutamate (Abcam, Cambridge, UK) was dissolved in 1 molar eq. NaOH and used at a final 
concentration of 1 mM. Excitatory glutamate agonists NMDA (Tocris, Bristol, UK), kainate (Tocris) 
and AMPA (Abcam) were dissolved in dH2O and used at 50 µM. The MEK1/2 inhibitor PD184352 
(Sigma, St. Louis, MO, USA), CaMKII inhibitor KN-62 (Cayman Chemical, Michigan, USA), PI3K 
inhibitor LY294002 (Tocris) and the NMDAR inhibitor D-AP5 (Tocris) were dissolved in DMSO and 
used at 2 µM, 10 µM, 10 µM and 50 µM, respectively. The cell-permeable phosphopeptide activator 
of PI3K, 740 Y-P (Tocris), was dissolved in dH2O and used at 10 µg/ml. The Na+ channel blocker 
tetrodotoxin (TTX) citrate (Abcam) was dissolved in dH2O and used at 2.5 µM. DMSO or NaOH at 
the corresponding concentrations were used as vehicle for control conditions. 
 
4.2 Immunofluorescence and confocal microscopy 
Postnatal day 8 male Sprague-Dawley rats were overdosed with anaesthetic, decapitated and the brain 
was removed from the skull. The brain was rapidly washed in 0.1 M PBS (pH 7.4) before fixing in 4% 
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paraformaldehyde in PBS at 4○C for 48 h. The brain was washed in PBS and 150 µm coronal PVN 
slices were obtained using an Intracel Vibratome 3000 sectioning system (Intracel, UK). Free-floating 
slices were permeabilised and blocked in ‘carrier solution’ [0.4% Triton X-100, 1% BSA in HBS 
(HEPES-buffered saline; 25 mM HEPES, pH 7.2; 119 mM NaCl; 5 mM KCl; 2 mM CaCl2; 2 mM 
MgCl2; 30 mM glucose)] for 6 hours at RT, followed by incubation with rabbit polyclonal anti-
vasopressin antibody (1:2000; AB1565, Millipore, Billerica, MA, USA) in carrier solution for 18 
hours at 4○C. Slices were washed five times in PBS (10 min per wash), incubated with AlexaFluor488-
conjugated goat anti-rabbit secondary antibody (1:500; Invitrogen) and DAPI (0.1 µg/ml) in carrier 
solution for 4 hours at RT, followed by washing as above. Slices were mounted onto gelatin-coated 
glass slides (Correa et al., 1998) and coverslips were mounted with Mowiol (Kuratay Europe GmbH, 
Frankfurt, Germany) as described (Canal et al., 2011; Eales et al., 2014). Immunofluorescent staining 
was observed using a 40x oil-immersion lens on a Zeiss LSM 510 Meta confocal microscope (Carl 
Zeiss, Oberkochen, Germany). Composite images shown in Fig 1A were generated by merging 65 
individual confocal images using AutoStitch v2.2 (Ma et al., 2007). 
 
4.3 Preparation and stimulation of acute PVN slices 
Postnatal day 8-12 male Sprague-Dawley rats were overdosed with anaesthetic, decapitated and brains 
were rapidly removed from the skull into ice-cold artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 
3 mM KCl, 2 mM CaCl2, 26 mM NaHCO3, 1.25 mM NaH2PO4, 10 mM D-glucose and 1 mM MgSO4, 
pH 7.4) bubbled with O2. A single coronal 450 µm PVN slice (at approximately Bregma -1.72 mm; 
see Fig 1A,B) per animal was obtained using an Intracel Vibratome 3000 sectioning system. The slices 
were trimmed so that they did not contain the SON, which is located at the ventral side of the slice. All 
slices were then divided into left and right hemispheres by carefully cutting along the third ventricle 
under a dissecting microscope. All experiments were conducted using the paired hemispheres so that 
the samples in each specific experiment were from the same animal. Subsequent steps were performed 
in oxygenated aCSF at 32°C. Each hemisphere was stabilised for 1 hour, pre-incubated for 1 hour in 
the appropriate reagents (TTX plus inhibitors or activators) and stimulated for 2 hours with the 
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appropriate agonists in the presence of the pre-incubation reagents. The exact composition of the 
reagents in each of the samples is indicated in the figures and the legends. 
 
4.4 RNA extraction and cDNA synthesis 
At the end of the 2 hour stimulation, total RNA was isolated from slices (each weighing approximately 
20 µg) by direct transfer into TRIzol reagent (Fisher Scientific, Loughborough, UK). Slices were 
disrupted using sterile pestles and homogenised by passage through a QIAshredder column (Qiagen, 
Limburg, Netherlands), followed by chloroform phase separation and purification using the PureLink 
RNA mini kit (Fisher Scientific). Purified RNA was subjected to on-column DNase treatment (Fisher 
Scientific) and the concentration and purity of the RNA was assessed spectrophotometrically using the 
NanoDrop ND-1000 (NanoDrop, Wilmington, DE, USA). RNA used for all further experiments had 
an A260/A280 ratio of 1.9 – 2.25. First-strand cDNA synthesis was performed with 500 ng RNA using 
M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) with 200 ng random hexamer primers 
(Fisher Scientific) in a total reaction volume of 20 µl, according to the manufacturer’s protocol.  
 
4.5 qRT-PCR 
Primers (Table 1) for the detection of β-actin mRNA, c-fos mRNA, AVP mRNA and AVP 
heteronuclear RNA (hnRNA) have been published elsewhere (Kawasaki et al., 2009; Zeybel et al., 
2012); GAPDH mRNA primers were designed with the help of Primer3Plus software (Untergasser et 
al., 2007). The levels of AVP hnRNA – rather than mRNA – were analysed here because they have 
been shown to acutely and reliably change in response to osmotic (Herman et al., 1991; Ponzio et al., 
2007; Yue et al., 2006) and other stimuli such as acute stress (Ma et al., 1997). In contrast, AVP 
mRNA is abundant and relatively unaffected by short-term stimuli. Therefore, measurement of AVP 
hnRNA was chosen for analysing acute changes in AVP gene expression.  
Reverse transcriptase PCR (RT-PCR) was performed using each set of primers as described (Shaheen 
et al., 2014; Wall et al., 2018) and amplification of a single correct product was checked by agarose 
gel electrophoresis followed by sequencing (GATC Biotech, London, UK). Primer standard curves 
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were performed to estimate the PCR efficiencies for each primer pair; the efficiencies of all five 
primer sets used in the current study were between 85 and 106%. qRT-PCR was performed using an 
AB 7500 Fast machine (Applied Biosystems, Life Technologies, Paisley, UK). cDNA was diluted 
1:50 in dH2O and each reaction comprised 5 µl diluted cDNA, 10 µl Precision (or PrecisionPlus) 2x 
real-time PCR MasterMix with SYBR green (Primerdesign, Southampton, UK) and 120 nM primers 
in a final volume of 20 µl. The PCR cycling conditions were as follows: 95○C for 10 min (for 
Precision; 2 min for PrecisionPlus), then 40 cycles of 95○C for 15 s, 60○C for 1 min, followed by melt 
curve recording between 60 and 95○C. Cycle threshold (Ct) values were determined by the AB 7500 
Fast software and were routinely checked manually. qRT-PCR reactions were run in triplicate and 
corresponding samples in a given experiment were run on the same plate. An additional reaction using 
the AVP hnRNA primers was performed on samples that had not been treated with reverse 
transcripase (-RT) to check for genomic DNA (gDNA) contamination; templates routinely had Ct 
differences >6 for the +RT versus –RT samples, representing little if any gDNA contamination. 
Table 1. Details of qRT-PCR primers used in the current study. 
Primer pairs Sequence Product (bp) TA (○C) TM (○C) 
GAPDH mRNA 5'-agttcaacggcacagtcaag (forward) 
5'-gtggtgaagacgccagtaga (reverse) 
148 60 82.2 
β-actin mRNA 5'-agccatgtacgtagccatcc (forward) 
5'-ctctcagctgtggtggtgaa (reverse) 
228 60 86.2 
c-fos mRNA 5'-agcatgggctcccctgtca (forward) 
5’-gagaccagagtgggctgca (reverse) 
134 60 84.1 
AVP mRNA 5'-tgcctgctacttccagaactgc (forward) 
5'-aggggagacactgtctcagctc (reverse) 
77 60 80.1 
AVP hnRNA 5'-gccctcacctctgcctgcta (forward) 
5'-cctgaacggaccacagtggt (reverse) 
100 60 82.8 
   TA, annealing temperature; TM, PCR product melting temperature. 
 
4.6 Data analysis 
AVP gene expression was measured as changes in AVP hnRNA, which has been shown to be a 
sensitive indicator of acute changes in AVP transcription (Herman et al., 1991; Ma et al., 1997; Ponzio 
et al., 2007; Yue et al., 2006). Normalisation was performed using the geometric mean of GAPDH, β-
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actin and AVP mRNA as reference. AVP mRNA was included in the reference to calibrate for the 
number of vasopressinergic PVN neurons present within the slices, as it has been shown that AVP 
neurons store relatively large levels of AVP mRNA and that its levels do not significantly change 
upon stimulation (Ma et al., 1997; Ponzio et al., 2007; Yue et al., 2006), in contrast to that of the 
hnRNA. ΔCt values for c-fos mRNA and AVP hnRNA were calculated by subtracting the geometric 
mean of GAPDH, β-actin and AVP mRNA Ct values from the relevant c-fos mRNA or AVP hnRNA 
mean Ct values. Relative quantification of c-fos mRNA and AVP hnRNA changes was performed 
using the 2-ΔΔCt method (Livak and Schmittgen, 2001). All treatments were performed in paired 
samples by using two hemispheres of the same animal’s PVN slice. Statistical differences between 
ΔCt values of paired treatments were evaluated using a paired two-tailed t test and data were analysed 
and presented as percentage of the appropriate control (without 1 of the applied reagents) using 
GraphPad Prism 6 (p<0.05 was considered significant). For graphical presentation of the variances, 
within-subject SEMs were calculated according to the method of Cousineau et al (Cousineau, 2005). 
In addition, graphs representing the differences of the means, together with the relevant 95% CIs, were 
prepared. 
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7. Figure Captions: 
Fig 1. Acute rat brain slices contain equal numbers of vasopressinergic neurons in both 
hemispheres. (A) Diagrammatic representation of the PVN. 3V, third ventricle; V, ventral part; DC, 
dorsal cap; LM, lateral magnocellular part; MP, medial parvicellular part. (B) Immunofluorescence 
staining of the PVN region using a specific antibody against AVP, clearly showing the 
vasopressinergic neurons in both hemispheres. DAPI was used to stain the nuclei. Scale bar = 200 µm. 
(C/D) Total RNA was extracted and the expression of AVP hnRNA (C) and c-fos mRNA (D) was 
measured in left and right hemispheres of 450 µm acute coronal rat PVN slices by qRT-PCR. ΔΔCt 
values were expressed as a percentage of ΔΔCt for the left hemisphere. The data are presented as the 
mean ± SEM (AVP hnRNA, n=4; c-fos mRNA, n=3). No significant difference was detected for either 
AVP hnRNA or c-fos mRNA expression between the two hemispheres (paired two-tailed t test). (E) 
The differences between ΔCt values for paired slices were calculated and the data presented are the 
mean of these differences, with the error bars representing the 95% CI.  
 
Fig 2. AVP gene expression in the rat PVN is stimulated by glutamatergic stimuli. The expression 
of AVP hnRNA was measured in 450 µm acute coronal rat PVN slices by qRT-PCR. Slices were 
dissected into left and right hemispheres, one of which was used as the paired control in each 
experiment. Slices were stabilised in aCSF at 32○C for 1 hour, followed by incubation with (or 
without) 2.5 µM TTX for 1 hour (A). In B/C, all slices were treated for 1 hour with 2.5 µM TTX, 
followed by incubation with (or without) 50 mM KCl (B) or 1 mM L-Glutamate (C) for 2 hours. Total 
RNA was then extracted and processed for analysis by qRT-PCR. AVP hnRNA ΔΔCt values were 
expressed as a percentage of ΔΔCt for control slices, and the data presented are the mean ± SEM (n=5 
per condition) [*p<0.05, ***p<0.001 (paired two-tailed t test)]. In addition, the differences between 
ΔCt values for paired slices were calculated and the data presented are the mean of these differences, 




Fig 3. The glutamatergic induction of AVP gene expression in the rat PVN is facilitated by 
NMDARs. The expression of AVP hnRNA was measured in 450 µm acute coronal rat PVN slices by 
qRT-PCR. Slices were dissected into left and right hemispheres, one of which was used as the paired 
control in each experiment. Slices were stabilised in aCSF at 32○C for 1 hour, followed by incubation 
with 2.5 µM TTX for another hour. Slices were then incubated with (or without) 50 µM NMDA (A), 
50 µM AMPA (B) or 50 µM kainate (C) for 2 hours (in the presence of TTX). Total RNA was then 
extracted and processed for analysis by qRT-PCR. In (D) slices were incubated with (or without) D-
AP5 together with TTX for 1 hour before stimulation with glutamate (in the presence of TTX plus 
vehicle or D-AP5) for 2 hours. AVP hnRNA ΔΔCt values were expressed as a percentage of ΔΔCt for 
slices in TTX alone, and the data presented are the mean ± SEM (n=3-4 per condition) [*p<0.05 
versus TTX alone (A-C) or TTX/glutamine (D); paired two-tailed t test]. In addition, the differences 
between ΔCt values for paired slices were calculated and the data presented are the mean of these 
differences, with the error bars representing the 95% CI. 
 
Fig 4. NMDAR-mediated AVP gene expression in the rat PVN is dependent on CaMKII, PI3K 
and ERK1/2. The expression of AVP hnRNA was measured in 450 µm acute coronal rat PVN slices 
by qRT-PCR. Slices were dissected into left and right hemispheres, one of which was used as the 
paired control in each experiment. Slices were stabilised in aCSF at 32○C for 1 hour, followed by a 1 
hour incubation with 2.5 µM TTX plus either (A) the CaMKII inhibitor KN-62 (10 µM), (B) the PI3K 
inhibitor LY294002 (10 µM), or (D) the MEK1/2 inhibitor PD184352 (2 µM). Slices were then 
incubated with 50 µM NMDA for 2 hours (in the presence of TTX and inhibitor). In (C), stabilised 
slices were incubated for 1 hour with 2.5 µM TTX, followed by a 2 hour incubation with 10 µg/ml 
740 Y-P in the presence of TTX. For all experiments, total RNA was extracted and processed for 
analysis by qRT-PCR. AVP hnRNA ΔΔCt values are expressed as a percentage of ΔΔCt relative to the 
corresponding control. The data are presented as the mean ± SEM (n=4-5 per condition) [*p<0.05, 
**p<0.01 (paired two-tailed t test)]. The differences between ΔCt values for paired slices were 
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calculated and the data presented are the mean of these differences, with error bars representing the 
95% CI. 
 
Fig 5. NMDAR-mediated AVP gene expression in the rat PVN is dependent on both PI3K- and 
ERK1/2-dependent pathways. The expression of AVP hnRNA was measured in 450 µm acute 
coronal rat PVN slices by qRT-PCR. Slices were dissected into left and right hemispheres, one of 
which was used as a paired control in each experiment. Slices were stabilised in aCSF at 32○C for 1 
hour. (A) Stabilised slices were incubated for another 1 hour in 2.5 µM TTX together with (or 
without) 2 µM PD184352. The slices were then incubated with 10 µg/ml 740 Y-P in the presence of 
TTX plus (or minus) inhibitor for a further 2 hours. (B) Stabilised slices were incubated for 1 hour 
with 2.5 µM TTX together with (or without) 2 µM PD184352, followed by a 2 hour incubation with 
50 µM NMDA plus 10 µM LY294002. Total RNA was extracted from all samples and processed for 
analysis by qRT-PCR. ΔΔCt values are expressed as a percentage of ΔΔCt relative to the paired 
control slices and the data presented are the mean ± SEM (a: n=7, b: n=5). [*p<0.05 (paired two-tailed 
t test)] The differences between ΔCt values for paired slices were calculated and the data presented are 
the mean, with the error bars representing the 95% CI. 
 





